Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 65 Neoplasms 29 Neoplasm Metastasis 11 Thyroid Neoplasms 10 Thyroid Carcinoma, Anaplastic 9 Glioma 9 Brain Neoplasms 9 Multiple Myeloma 7 Colorectal Neoplasms 7 Carcinoma, Non-Small-Cell Lung 7 Hematologic Neoplasms 6 Thyroid Cancer, Papillary 4 Skin Neoplasms 4 Ameloblastoma 4 Histiocytosis, Langerhans-Cell 3 Glioblastoma 3 Astrocytoma 3 Rectal Neoplasms 2 Prostatic Neoplasms 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Oligodendroglioma 2 Neurofibroma, Plexiform 2 Neurocytoma 2 Neuroblastoma 2 Lymphoma, Non-Hodgkin 2 Lymphoma 2 Lung Neoplasms 2 Ganglioneuroma 2

Interventions

Surgical Procedures, Operative 4 Magnetic Resonance Spectroscopy 3 Exenatide 3 tocilizumab 2 Temozolomide 2 Radiotherapy 2 Proton Therapy 2 Mental Status and Dementia Tests 2 Donepezil 2 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2 trifluridine tipiracil drug combination 1 trametinib 1 tozuleristide 1 tovorafenib 1 temsirolimus 1 gallium Ga 68 dotatate 1 entinostat 1 dabrafenib 1 cobimetinib 1 carboxyamido-triazole 1 binimetinib 1 antineoplaston AS 2-1 1 antineoplaston A10 1 anlotinib 1 Verteporfin 1 Vemurafenib 1 Transurethral Resection of Bladder 1 Thalidomide 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Image-Guided 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Craniopharyngioma × dabrafenib × Clear all

NCT05525273 2024-02-14

Swecranio

Skane University Hospital

Phase 2 Recruiting

Craniopharyngioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡